UBS has increased its price target for CDW Corporation to $195 from $159, while reiterating its Buy rating. This adjustment follows the company's recent quarterly earnings report, suggesting a positive re-evaluation of CDW's financial outlook by the firm.
UBS has raised its price target for CDW Corporation from $159 to $195, while keeping its 'Buy' rating. This revision comes after CDW's recent quarterly earnings disclosure, indicating that UBS analysts likely found the earnings report to be stronger than previously anticipated or that their valuation model has been updated to reflect improved future prospects. This news is generally positive for CDW, as it signals a vote of confidence from a major investment bank, potentially attracting more investors and supporting the stock price in the short term. For traders, this could present an opportunity for upward momentum, though the long-term implications depend on CDW's continued performance and broader market conditions. The key risk is that the market may have already priced in the positive earnings, limiting further upside from this specific analyst action.